עמוד בית Fri, 23.08.19

31.10.2018: Statement on Biosimilar Medicinal Products Adopted by the WMA

 

A statement on Biomedical Products written by the Israeli Medical Association was adopted at the  62nd General Assembly of the World Medical Association held in Reykjavik, Iceland, October 2018.
 

Legal Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal or medical advice on any matter. The IMA is not responsible for and expressly disclaims liability for damages of any kind arising from the use of or reliance on information contained within the site.

© All rights to information on this site are reserved and are the property of the Israeli Medical Association. Privacy policy